Home
NRTI
NNRTI
PI
Fusion Inhibitors
Entry Inhibitors
Integrase Inhibitors

Protease Inhibitors (PI)

Up
Aptivus
Crixivan
Norvir
Lexiva
Invirase
Viracept
Kaletra
Agenerase
Prezista
Reyataz

One of a class of anti-HIV drugs designed to inhibit the enzyme protease and thereby interfere with virus replication.

Protease inhibitors prevent proteases from splitting proteins into peptides. Protease inhibitors prevent the cleavage of HIV precursor proteins into active proteins, a process that normally occurs when HIV replicates.

Protease inhibitors include saquinavir (brand name: Invirase, Fortovase) and ritonavir (brand name: Norvir) and are used primarily in HIV/AIDS treatment. They are taken as part of a two- or three-drug cocktail, accompanied by one or more nucleoside antiviral drugs.

These treatments are capable of lowering the level of HIV virus in the blood until it cannot be measured with current tools. Side effects associated with protease inhibitors include a lipodystrophy syndrome in which the face, arms and legs become thin due to loss of subcutaneous fat, the skin becomes dry, weight loss occurs, and abnormal deposits of fat occur. Some new strains of HIV are resistant to protease inhibitors.

When HIV infects a CD4 cell in a person's body, it copies its own genetic code into the cell's DNA. The CD4 cell is then "programmed" to make new HIV genetic material and HIV proteins. The proteins must be cut up by the HIV protease - a protein-cutting enzyme - to make functional new HIV particles. PIs block the protease enzyme and prevent the cell from producing new viruses. It is recommended that they be used in combination with at least two other HIV drugs to treat HIV infection.

Protease Inhibitors (PI) drugs list :

Brand Name Generic Name Manufacturer Name
Aptivus tipranavir, TPV Boehringer Ingelheim
Crixivan indinavir, IDV Merck
Norvir ritonavir, RTV Abbott Laboratories
Lexiva Fosamprenavir Calcium, FOS-APV GlaxoSmithKline
Invirase saquinavir mesylate, SQV Hoffmann-La Roche
Viracept nelfinavir mesylate, NFV Agouron Pharmaceuticals
Kaletra lopinavir and ritonavir, LPV/RTV Abbott Laboratories
Agenerase amprenavir, APV GlaxoSmithKline
Prezista darunavir Tibotec, Inc.
Reyataz atazanavir sulfate, ATV Bristol-Myers Squibb